Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000015 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 12, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
90,000
Total Value
$1,826,160.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 30,000 | $10.42 | $312,600.00 | 30,000 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Mar 10, 2026 | Sale | 29,652 | $50.45 | $1,495,807.00 | 348 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Mar 10, 2026 | Sale | 348 | $51.02 | $17,753.22 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Mar 10, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 267,407 | Direct | โ | View Details |